Our Approach to Innovation
 

Our Mission is to Simplify Life for People with Diabetes and to Simplify Diabetes Care


The future is bright for the #1 Voted Favorite Pump in the US1!

 

With Omnipod® 5 we created the first and only tubeless Automated Insulin Delivery (AID) system in the US, but we’re not stopping there. We’re continuing to lead the tubeless pump revolution by diligently working on offering our consumers a choice of phone operating system for the Omnipod 5 App and also sensor of choice among the biggest sensors available on the market.

What's New

FDA Clearance of Omnipod 5 for Adults with Type 2 Diabetes

We have groundbreaking news that Omnipod 5 is now indicated for people with type 2 diabetes (ages 18 years and older) in the United States! This makes it the first and only automated insulin delivery system FDA-cleared for both type 1 and type 2 diabetes management. For any questions, read our FAQs here.

Omnipod 5 App for iPhone

Omnipod 5 App for iPhone with Dexcom G6 is available! Now your patients can enjoy the freedom and convenience of controlling the Pod from a compatible iPhone or Android smartphone without the need to carry the Controller.2 For any questions, read our FAQs here.

Omnipod 5 and Dexcom G7

We're excited to announce that Omnipod 5 integration with Dexcom G7 is now broadly available in retail pharmacies across the U.S.! This is another step toward our goal of offering Omnipod 5 users a choice of CGM sensor. For any questions, read our FAQs here.

Omnipod® 5 and FreeStyle Libre 2 Plus Sensor

The Omnipod® 5 System is now integrated with the FreeStyle Libre 2 Plus Sensor! With this new sensor integration, users will benefit from tubeless automated insulin delivery along with the convenience of a 15-day wear CGM sensor, and the ability to start, deactivate, and view sensor glucose data directly from the Omnipod 5 Controller. FAQs here

What's Next

Sensor Integration

We are proud to partner with Dexcom and Abbott to expand our Omnipod 5 sensor integration options, giving users choice in the device they use for glucose monitoring.

Frequently Asked Questions


Stay in the Know About Innovation and Other Omnipod News

“The Pod is a revolution in insulin therapy - No tubes, less needle sticks, constant insulin delivery for 3 days - no disconnect. All of these factors improve adherence among people with diabetes and, as a result, dramatically improve clinical outcomes and quality of life.”

Dr. Michael R. Brennan

D.O., M.S., F.A.C.E., F.A.C.P., is an award-winning endocrinology, diabetes and metabolism specialist and founder of the Beaumont Endocrine Center. Dr. Brennan has an ongoing commercial relationship with Insulet.

Get the Latest Updates

Healthcare Providers: Be the first to hear about updates from the Omnipod® Team.

Sign Up Now

A Look Behind the Scenes


 

Awards & Recognition

Our greatest reward is the impact our products have on the people who use them and their caregivers. We’re also pleased that our hard work and advanced approach have been recognized by industry organizations.

HCP with young podder patient and parent HCP with young podder patient and parent

2022

Omnipod 5 Voted #1 Favorite Pump in the US, Patient Choice Award Winner**

2021

Top Ten Wearable Medical Device Solution Provider, according to MD Tech Review

2020

Top Ten Wearable Medical Device Solution Provider, according to MD Tech Review

Omnipod DASH® System named the 2020 Product of the Year in the Health Systems Category by 40,000 U.S. Consumers

*The Omnipod brand was named 2022 Patient Choice Award Winner for preferred pump; Seagrove Patient Perspectives Survey Report (304 Total Responses, 229 T1D, 75 T2D - 203 pumpers, 64 MDI, 37 non-MDI). Seagrove Partners, LLC Patient Perspectives Report, December 2022. Insulet data on file.
Pod shown without the necessary adhesive.

Innovation in Every Pod

One small, tubeless and waterproof2 Pod, which is made up of 74 pieces, consistently and accurately delivers insulin for people with diabetes through customizable basal rates and bolus presets.

The Pod holds up to 200 units of rapid-acting U-100 insulin and replaces up to 14 daily injections.3

The Pod includes auto-cannula insertion, that eliminates the necessity of handling the insertion needle, while providing a virtually pain-free path for insulin delivery.

Insulet Product Roadmap

We are dedicated to reducing complexity and making diabetes management simpler. Our ongoing commitment to the diabetes community is our continuous innovation, aiming to continually make products smarter and simpler. 

The Omnipod® 5 System is the first and only  FDA-cleared tubeless Automated Insulin Delivery System! 

Omnipod 5 w Dexcom G6 Controller Omnipod 5 w Dexcom G6 Controller
Pod and Dexcom G6 shown without necessary adhesive.

Register for Omnipod® Connect!

Omnipod® Connect is designed to help HCPs learn more about Omnipod® products, including the Omnipod® 5 System. We have developed several e-learning modules in bite-sized lessons, so you can learn about the System and familiarize yourself with best practices for initiation ahead of product availability. You can also connect virtually with an Omnipod® 5 clinical trial investigator through a dedicated 30-minute webinar with live Q&A.

Register for Omnipod® Connect
 
 

“The Pod is a revolution in insulin therapy - No tubes, less needle sticks, constant insulin delivery for 3 days - no disconnect. All of these factors improve adherence among people with diabetes and, as a result, dramatically improve clinical outcomes and quality of life.”

Dr. Michael R. Brennan

D.O., M.S., F.A.C.E., F.A.C.P., is an award-winning endocrinology, diabetes and metabolism specialist and founder of the Beaumont Endocrine Center. Dr. Brennan has an ongoing commercial relationship with Insulet.

Get the Latest Updates

Healthcare Providers: Be the first to hear about updates from the Omnipod® Team.

Sign Up Now

Hear from Industry Experts and Innovation Leaders

“Our research and development team continues to push the boundaries of what’s possible. Through device miniaturization, therapy automation through artificial intelligence, and integration with consumer technologies, we create simple products that deliver great outcomes and reduce the burden for people with diabetes - and those who care for them.”

—Eric Benjamin SVP, Innovation and Strategy, Insulet Corporation

Video URL
https://www.youtube.com/watch?v=nq-g1kOMUhQ

 
Awards & Recognition

Our greatest reward is the impact our products have on the people who use them and their caregivers. We’re also pleased that our hard work and advanced approach have been recognized by industry organizations.

2022

  • Omnipod 5 Voted #1 Favorite Pump in the US, Patient Choice Award Winner*

2021

  • Top Ten Wearable Medical Device Solution Provider, according to MD Tech Review

2020

  • Top Ten Wearable Medical Device Solution Provider, according to MD Tech Review
  • Omnipod DASH® System named the 2020 Product of the Year in the Health Systems Category by 40,000 U.S. Consumers

The Human Side of Innovation - About the Team

What Does it Mean to Work on The Innovation Team at Insulet?

We’re passionate about pioneering new ways of thinking – whether that results in a product, a system, a process, or a pivot from prior ways of thinking to new insights.

What Makes Our Innovation Team Stand Out?

  • An implicit freedom to challenge the status quo
  • Technical skills, combined with critical thinking and creativity
  • Collaboration combined with deep focus
  • Diversity of thought and background

1. The Omnipod brand was named 2022 Patient Choice Award Winner for preferred pump; Seagrove Patient Perspectives Survey Report (304 Total Responses, 229 T1D, 75 T2D - 203 pumpers, 64 MDI, 37 non-MDI). Seagrove Partners, LLC Patient Perspectives Report, December 2022. Insulet data on file.

2. For a list of compatible smartphone devices visit omnipod.com/compatibility

References:
1. https://www.healthline.com/diabetesmine/artificial-intelligence-daily-life-with-diabetes and https://www.youtube.com/watch?v=ST45EcJ82a0
2. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof.
3. 14 injections/day based on people with T1D on MDI taking ≥ 3 boluses and 1-2 basal injections/day multiplied by 72 hours. Chiang et al. Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association. Diabetes Care. 2014:37:2034-2054.
4. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 controller is not waterproof
5. Dexcom G6® CGM System is sold separately
6.For a list of compatible smartphone devices visit omnipod.com/compatibility